Oncology

Foundation Medicine and Sarah Cannon Research Institute work together to increase access to clinical trials for personalized oncology treatments.

Sofosbuvir adherence in hepatitis C patients impacted by a mental health disease.

Opdivo is approved for metastatic melanoma, non-small cell lung cancer, renal cell carcinoma, and classical Hodgkin lymphoma.

A newly identified metabolic fingerprint of colorectal cancer may serve as a future diagnostic tool in early detection.

Research evaluates sofosbuvir use in hepatitis C patients with a mental health disease.

A 2-year study will examine the effectiveness of advanced MRI to determine response to breast cancer treatment.

The companies plan to collaborate on clinical trials of a novel combination therapy for multiple myeloma.

Interfering with energetic metabolism may stop glioblastoma growth and recurrence.

Rehabilitation with the help of the internet ameliorates life quality and side effects in women with breast cancer.

The proportion of cancer deaths attributable to smoking differs among states, but the highest proportion was seen in the Southern United States.

Top news of the day from across the health care landscape.

Total thyroidectomy is the most common treatment for thyroid cancer.

Ribociclib seeks approval as a first-line treatment of postmenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative advanced or metastatic breast cancer.

The FDA has accepted Novartis’ New Drug Application (NDA) and granted Priority Review for LEE011 (ribociclib).

A chemical inhibitor was found to limit the growth of lung tumor cells and may provide better treatment for lung cancer patients.

HIV positive patients coinfected with hepatitis may face elevated cancer risk.

Stay up-to-date with the hottest news in pharmacy!

Tumor markers can help guide future treatments for patients with bladder cancer.

Top news of the week in oncology and cancer drug development.

Developed countries may be able to assist developing countries in ensuring their drugs are safe.

Top news of the day from across the health care landscape.

Testing method could improve radioembolization technique in cancer treatment.

Newly-discovered compound blocks an essential protein in sustaining tumor growth.

Keytruda approved as a first-line treatment for non-small cell lung cancer.

Swedish study suggests that more American men can opt surveillance over prostate cancer treatment.

Astellaas Pharma has entered into an agreement to acquire Ganymed and its investigational cancer antibodies.

Triolimus contains paclitaxel plus 2 agents to prevent chemotherapy resistance.

Injections of nanoliposomes reversed memory loss associated with Alzheimer’s disease in mouse models.